Literature DB >> 32238379

ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease.

Cara Reiter-Brennan1,2, Albert D Osei1, S M Iftekhar Uddin1, Olusola A Orimoloye1,3, Olufunmilayo H Obisesan1, Mohammadhassan Mirbolouk1,4, Michael J Blaha1, Omar Dzaye5,6,7.   

Abstract

The 2018 and 2019 guidelines from the American College of Cardiology and American Heart Association reflect the complexity of individualized cholesterol management. The documents address more detailed risk assessment, newer nonstatin cholesterol-lowering drugs, special attention to patient subgroups, and consideration of the value of therapy, all with the aim of creating personalized treatment plans for each patient. Overall, the guidelines recommend shared decision-making to meet the individual needs of each patient.
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32238379     DOI： 10.3949/ccjm.87a.19078

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  8 in total

1.  Heterogeneity in statin responses explained by variation in the human gut microbiome.

Authors:  Tomasz Wilmanski; Sergey A Kornilov; Christian Diener; Matthew P Conomos; Jennifer C Lovejoy; Paola Sebastiani; Eric S Orwoll; Leroy Hood; Nathan D Price; Noa Rappaport; Andrew T Magis; Sean M Gibbons
Journal:  Med (N Y)       Date:  2022-05-11

2.  Association between deficient and insufficient 25(OH)D serum concentrations and cardiometabolic risk factors: Findings of a population-based study with older adults of southern Brazil.

Authors:  Francieli Cembranel; Alexandra Crispim Boing; Antonio Fernando Boing; André Junqueira Xavier; Eleonora d'Orsi
Journal:  Prev Med Rep       Date:  2021-10-07

3.  Association of Physical Activity with Lipid Profile in Healthy Subjects: A Cross Sectional Study in Tertiary Care Hospital from Central Rural India.

Authors:  Babita Bondge; Jyoti Jain; Mangesh Warkad; Madhura Joshi; Subhash More; Saiprasath Janaarthanan
Journal:  Indian J Endocrinol Metab       Date:  2022-02-17

4.  Effects of Apnea, Obesity, and Statin Therapy on Proprotein Convertase Subtilisin/Kexin 9 Levels in Patients with Obstructive Sleep Apnea.

Authors:  Ana Milojević; Marija Zdravković; Milica Brajković; Lidija Memon; Vera Gardijan; Jelena Vekić; Aleksandra Zeljković; Aleksandra Stefanović; Marija Mihajlović; Jasmina Ivanišević; Nataša Bogavac-Stanojević; Vojislav Radosavljević; Vesna Spasojević-Kalimanovska; Ana Ninić
Journal:  Med Princ Pract       Date:  2022-03-15       Impact factor: 2.132

5.  Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study.

Authors:  Jiahang Li; Zhenxing Nie; Zhongli Ge; Lei Shi; Bin Gao; Yan Yang
Journal:  Lipids Health Dis       Date:  2022-08-25       Impact factor: 4.315

6.  An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies.

Authors:  Min-Han Chi; Jung Chao; Chien-Yu Ko; Shyh-Shyun Huang
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

7.  Central blood pressure lowering effect of telmisartan-rosuvastatin single-pill combination in hypertensive patients combined with dyslipidemia: A pilot study.

Authors:  JungMin Choi; Ki-Chul Sung; Sang-Hyun Ihm; Chang-Hwan Yoon; Seung Woo Park; Sung-Ha Park; Jang-Young Kim; Sung-Uk Kwon; Hae-Young Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-08-12       Impact factor: 3.738

8.  Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.

Authors:  Alexander Hodkinson; Dialechti Tsimpida; Evangelos Kontopantelis; Martin K Rutter; Mamas A Mamas; Maria Panagioti
Journal:  BMJ       Date:  2022-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.